Effects of oral magnesium supplementation on glycaemic control in Type 2 diabetes: A meta-analysis of randomized double-blind controlled trials

Diabetic Medicine

Volumn 23, Issue 10, 2006, Pages 1050-1056

  Song, Y ^a,b   He, K ^c   Levitan, E B ^a,b   Manson, J E ^a,b   Liu, S ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Controlled trials; Glycaemic control; HbA1c levels; Magnesium supplementation; Meta analysis

Indexed keywords

ASCORBIC ACID; CHOLESTEROL; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN; MAGNESIUM; MAGNESIUM ASPARTATE; MAGNESIUM CHLORIDE; MAGNESIUM CITRATE; MAGNESIUM OXIDE; PLACEBO; PYROGLUTAMATE MAGNESIUM;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIABETES CONTROL; DIABETIC DIET; DIABETIC PATIENT; DIARRHEA; DIASTOLIC BLOOD PRESSURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; GASTROINTESTINAL SYMPTOM; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMOGLOBIN DETERMINATION; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MEDLINE; NAUSEA; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; REFERENCE DATABASE; STATISTICAL ANALYSIS; SYSTOLIC BLOOD PRESSURE; THERAPY EFFECT; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADMINISTRATION, ORAL; AGED; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPOGLYCEMIA; MAGNESIUM; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 33748757640     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2006.01852.x     Document Type: Article

References (28)

1. Tosiello L. Hypomagnesemia and diabetes mellitus. A review of clinical implications. Arch Intern Med 1996; 156: 1143-1148.
2. Barbagallo M, Dominguez LJ, Galioto A, Ferlisi A, Cani C, Malfa L et al. Role of magnesium in insulin action, diabetes and cardio-metabolic syndrome X. Mol Aspects Med 2003; 24: 39-52.
3. Song Y, Manson JE, Buring JE, Liu S. Dietary magnesium intake in relation to plasma insulin levels and risk of type 2 diabetes in women. Diabetes Care 2004; 27: 59-65.
4. Itoh K, Kawasaka T, Nakamura M. The effects of high oral magnesium supplementation on blood pressure, serum lipids and related variables in apparently healthy Japanese subjects. Br J Nutr 1997; 78: 737-750.
5. Song Y, Ridker PM, Manson JE, Cook NR, Buring JE, Liu S. Magnesium intake, C-reactive protein, and the prevalence of metabolic syndrome in middle-aged and older US women. Diabetes Care 2005; 28: 1438-1444.
6. Touyz RM. Role of magnesium in the pathogenesis of hypertension. Mol Aspects Med 2003; 24: 107-36.
7. Chakraborti S, Chakraborti T, Mandal M, Mandal A, Das S, Ghosh S. Protective role of magnesium in cardiovascular diseases: a review. Mol Cell Biochem 2002; 238: 163-179.
8. Seelig MS, Heggtveit HA. Magnesium interrelationships in ischemic heart disease: a review. Am J Clin Nutr 1974; 27: 59-79.
9. Gullestad L, Jacobsen T, Dolva LO. Effect of magnesium treatment on glycemic control and metabolic parameters in NIDDM patients. Diabetes Care 1994; 17: 460-461.
10. Karppanen H, Tanskanen A, Tuomilehto J, Puska P, Vuori J, Jantti V, Seppanen ML. Safety and effects of potassium- and magnesium-containing low sodium salt mixtures. J Cardiovasc Pharmacol 1984; 6: S236-243.
11. Sjogren A, Floren CH, Nilsson A. Oral administration of magnesium hydroxide to subjects with insulin-dependent diabetes mellitus: effects on magnesium and potassium levels and on insulin requirements. Magnesium 1988; 7: 117-122.
12. Yokota K, Kato M, Lister F, Li H, Hayakawa T, Kikuta T et al. Clinical efficacy of magnesium supplementation in patients with type 2 diabetes. J Am Coll Nutr 2004; 23: 506S-509S.
13. de Lourdes Lima M, Cruz T, Carreiro Pousada J, Rodrigues LE, Barbosa K, Canguca V. The effect of magnesium supplementation in increasing doses on the control of type 2 diabetes. Diabetes Care 1998; 21: 682-686.
14. de Valk HW, Verkaaik R, van Rijn HJ, Geerdink RA, Struyvenberg A. Oral magnesium supplementation in insulin-requiring type 2 diabetic patients. Diabet Med 1998; 15: 503-507.
15. Eibl NL, Kopp HP, Nowak HR, Schnack CJ, Hopmeier PH, Schernthaner G. Hypomagnesemia in type II diabetes: effect of a 3-month replacement therapy. Diabetes Care 1995; 18: 188-192.
16. Eriksson J, Kohvakka A. Magnesium and ascorbic acid supplementation in diabetes mellitus. Ann Nutr Metab 1995; 39: 217-223.
17. Paolisso G, Sgambato S, Pizza G, Passariello N, Varricchio M, D'Onofrio F. Improved insulin response and action by chronic magnesium administration in aged NIDDM subjects. Diabetes Care 1989; 12: 265-269.
18. Paolisso G, Scheen A, Cozzolino D, Di Maro G, Varricchio M, D'Onofrio F, Lefebvre PJ. Changes in glucose turnover parameters and improvement of glucose oxidation after 4-week magnesium administration in elderly non-insulin-dependent (type II) diabetic patients. J Clin Endocrinol Metab 1994; 78: 1510-1514.
19. Purvis JR, Cummings DM, Landsman P, Carroll R, Barakat H, Bray J et al. Effect of oral magnesium supplementation on selected cardiovascular risk factors in non-insulin-dependent diabetics. Arch Fam Med 1994; 3: 503-508.
20. Rodriguez-Moran M, Guerrero-Romero F. Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects: a randomized double-blind controlled trial. Diabetes Care 2003; 26: 1147-1152.
21. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17: 1-12.
22. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomized controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet 1999; 354: 1896-900.
23. DerSimonian R, Laird NM. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188.
24. Egger M, Smith GD, Altman DG. Systematic Reviews in Health Care: Meta-Analysis in Context. London: BMJ Books, 2001.
25. Paolisso G, Barbagallo M. Hypertension, diabetes mellitus, and insulin resistance: the role of intracellular magnesium. Am J Hypertens 1997; 10: 346-355.
26. Gerich JE. Clinical significance, pathogenesis, and management of postprandial hyperglycemia. Arch Intern Med 2003; 163: 1306-1316.
27. American Diabetes Association (ADA). Nutrition recommendations and principles for people with diabetes mellitus. Diabetes Care 2000; 23: S43-6.
28. Dupont WD, Plummer WD Jr. Power and sample size calculations. A review and computer program. Control Clin Trials 1990; 21: 116-128.